News

Published on 29 Mar 2024 on Zacks via Yahoo Finance

Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?


Article preview image

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Stryker (SYK) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

Stryker is one of 1062 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Stryker is currently sporting a Zacks Rank of #2 (Buy).

NASDAQ.ATHA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Athira Pharma Insider Ups Holding By 111% During Year

From what we can see, insiders were net buyers in Athira Pharma, Inc.'s (NASDAQ:ATHA ) during the...

Simply Wall St. · via Yahoo Finance 18 Dec 2024

Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In...

Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mi...

Benzinga · via Yahoo Finance 19 Aug 2024

retail investors who own 35% along with institutions invested in Athira Pharma,...

Key Insights The considerable ownership by retail investors in Athira Pharma indicates that they ...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

One Athira Pharma Insider Raised Their Stake In The Previous Year

Viewing insider transactions for Athira Pharma, Inc.'s (NASDAQ:ATHA ) over the last year, we see ...

Simply Wall St. via Yahoo Finance 24 Apr 2024

Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 29 Mar 2024

Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 28 Feb 2024

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of...

Key Insights Significantly high institutional ownership implies Athira Pharma's stock price is...

Simply Wall St. · via Yahoo Finance 25 Jan 2024

Athira Pharma Insiders Placed Bullish Bets Worth US$556.3k

Generally, when a single insider buys stock, it is usually not a big deal. However, when several ...

Simply Wall St. via Yahoo Finance 15 Nov 2023

Athira Pharma, Inc. (ATHA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The price trend for Athira Pharma, Inc. (ATHA) has been bearish lately and the stock has lost 10....

Zacks via Yahoo Finance 29 Aug 2023

FDA Rejects ImmunityBio's (IBRX) Bladder Cancer Therapy Filing

Shares of ImmunityBio IBRX were down 55.1% on Thursday after management announced that FDA issued...

Zacks via Yahoo Finance 12 May 2023